Results 141 to 150 of about 2,965 (199)

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18:Transporters [PDF]

, 2017
,, Alexander, Stephen Ph, Davies, Jamie A, Faccenda, Elena, Harding, Simon D, Kelly, Eamonn, Marrion, Neil V, Pawson, Adam J, Peters, John A, Sharman, Joanna L, Southan, Christopher   +10 more
core   +10 more sources

Treatment With a Patented 3.6:1 Myo-Inositol to D-chiro-Inositol Ratio, Antioxidants, Vitamins and Minerals Food Supplement in Women With a History of Assisted Reproductive Technique (ART) Failures: A Series of Case Reports. [PDF]

Clin Med Insights Case Rep
Armijo-Sánchez A, Benítez Castillo N, García-Vidal E, Luna Chadid M, Salvador Ballada C, Valls Ricart G, Torres Pellens V.   +6 more
europepmc   +1 more source

Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial [PDF]

, 2015

core   +1 more source

Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study. [PDF]

J Ovarian Res, 2019
Troisi J, Cinque C, Giugliano L, Symes S, Richards S, Adair D, Cavallo P, Sarno L, Scala G, Caiazza M, Guida M.   +10 more
europepmc   +1 more source

Weltkongresse für gynäkologische Endokrinologie: Schweizer Fortbildung zu gynäkologisch-endokrinologischen Beiträgen [PDF]

, 2018
Stute, P., von Wolff, M.
core  

D-Chiro-Inositol's action as aromatase inhibitor: rationale and potential clinical targets.

European review for medical and pharmacological sciences, 2019
Laganà AS, Unfer V
openaire   +3 more sources

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. [PDF]

Cochrane Database Syst Rev, 2017
Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH.   +4 more
europepmc   +1 more source

D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress. [PDF]

Acta Pharmacol Sin, 2018
Zhao SS, Li NR, Zhao WL, Liu H, Ge MX, Zhang YX, Zhao LY, You XF, He HW, Shao RG.   +9 more
europepmc   +1 more source

The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.

Gynecol Obstet Invest
Pustotina O, Myers SH, Unfer V, Rasulova I.   +3 more
europepmc   +1 more source

d-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI).

Gynecol Obstet Invest
Dinicola S, Unfer V, Soulage CO, Yap-Garcia MIM, Bevilacqua A, Benvenga S, Barbaro D, Wdowiak A, Nordio M, Dewailly D, Appetecchia M, Aragona C, Espinola MSB, Bizzarri M, Cavalli P, Colao A, D'Anna R, Vazquez-Levin MH, Hernàndez Marin I, Kamenov Z, Laganà AS, Monastra G, Montanino Oliva M, Cenk Özay A, Pintaudi B, Porcaro G, Pustotina O, Pkhaladze L, Prapas N, Roseff S, Salehpour S, Stringaro A, Tugushev M, Unfer V, Vucenik I, Facchinetti F.   +35 more
europepmc   +1 more source